- Home
- PRAX vs HROW Comparison
PRAX vs HROW Comparison
Compare PRAX & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- HROW
- Stock Information
- Founded
- PRAX 2015
- HROW 1998
- Country
- PRAX United States
- HROW United States
- Employees
- PRAX N/A
- HROW N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- PRAX Health Care
- HROW Health Care
- Exchange
- PRAX Nasdaq
- HROW Nasdaq
- Market Cap
- PRAX 1.5B
- HROW 1.3B
- IPO Year
- PRAX 2020
- HROW N/A
- Fundamental
- Price
- PRAX $70.54
- HROW $33.85
- Analyst Decision
- PRAX Strong Buy
- HROW Strong Buy
- Analyst Count
- PRAX 9
- HROW 4
- Target Price
- PRAX $146.33
- HROW $55.00
- AVG Volume (30 Days)
- PRAX 309.5K
- HROW 328.0K
- Earning Date
- PRAX 03-04-2025
- HROW 11-13-2024
- Dividend Yield
- PRAX N/A
- HROW N/A
- EPS Growth
- PRAX N/A
- HROW N/A
- EPS
- PRAX N/A
- HROW N/A
- Revenue
- PRAX $1,605,000.00
- HROW $169,138,000.00
- Revenue This Year
- PRAX N/A
- HROW $50.31
- Revenue Next Year
- PRAX N/A
- HROW $47.75
- P/E Ratio
- PRAX N/A
- HROW N/A
- Revenue Growth
- PRAX N/A
- HROW 48.15
- 52 Week Low
- PRAX $33.01
- HROW $9.13
- 52 Week High
- PRAX $86.93
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- PRAX 46.51
- HROW 41.48
- Support Level
- PRAX $60.07
- HROW $32.93
- Resistance Level
- PRAX $71.21
- HROW $36.13
- Average True Range (ATR)
- PRAX 4.07
- HROW 1.88
- MACD
- PRAX -0.79
- HROW 0.18
- Stochastic Oscillator
- PRAX 49.11
- HROW 28.60
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.